Abstract
The Global Initiative for Obstructive Lung Disease defines chronic obstructive lung (pulmonary) disease (COPD) as “a common, preventable and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases.” Patients with COPD frequently have a combination of obstructive bronchiolitis or small-airway disease and parenchymal destruction or emphysema.
| Original language | English (US) |
|---|---|
| Title of host publication | Faust's Anesthesiology Review |
| Publisher | Elsevier |
| Pages | 62-65 |
| Number of pages | 4 |
| ISBN (Electronic) | 9780323879163 |
| ISBN (Print) | 9780323567008 |
| DOIs | |
| State | Published - Jan 1 2023 |
| Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2024, 2020, 2015, 2022, 1994, 1991 by Mayo Foundation.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- anesthetic considerations for obstructive/restrictive lung disease
- bronchitis
- chronic obstructive pulmonary disease
- restrictive lung disease
- smoking cessation
Fingerprint
Dive into the research topics of 'Chronic obstructive pulmonary disease and restrictive lung disease'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS